HC Wainwright reiterates Buy on Connect Biopharma, $7 target
HC Wainwright & Co. reiterated a Buy rating on Connect Biopharma Holdings and set a $7.00 price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.